Company
Overview
Leadership
Social Accountability
Technology
RJX Technology
Therapeutic Areas
Pipeline
Clinical Trials
Contact
Contact Us
Join Reven
News
Latest News
Research
Investor Portal
2018/12/05 Reven News Press
December 5, 2018
| Featured
SAD Cohort 6C doses subjects; SAD Cohort 6 is completed.
More Reven News Releases
|
More Research & Development